DT-109
| Overview | |
| Catalog # | bs-83459c-100mg |
| Product Name | DT-109 |
| Specifications | |
| Storage Buffer | White solid |
| Storage Condition | -20°C |
| Target | |
| Product Information | Glycine-containing peptide which has been demonstrated to ameliorate nonalcoholic fatty liver disease (NAFLD). It improved body composition, and lowered circulating glucose, lipids, transaminases, proinflammatory cytokines and steatohepatitis in mice with established NASH.1 It dose-dependently attenuates NASH and fibrosis in mice as well as in nonhuman primates.2 It induced glutathione biosynthesis in mononuclear cells and demonstrated atheroprotective activity.3 |
| Description | CAS Number: 14857-82-0 Chemical Name: Induces glutathione biosynthesis Molecular Weight: 245.26 Formula: C10H19N3O4 Solubility: DMSO (25 mg/ml, with warming) Water (25 mg/ml) Physical Properties: White solid Purity: >98% by TLC NMR (Conforms) |